New Leaf Venture Partners’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

New Leaf Venture Partners’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-85,638	Closed	-$1.31M	–	16
2018 Q1	$1.31M	Sell	85,638 -20,612	-19%	-$491K	0.71%	13
2017 Q4	$3.47M	Buy	106,250 +43,750	+70%	+$1.18M	1.62%	11
2017 Q3	$1.47M	Buy	+62,500	New	+$701K	0.68%	15
2016 Q2	–	Sell	-176,143	Closed	-$3.79M	–	17
2016 Q1	$3.79M	Hold	176,143	–	–	3.43%	10
2015 Q4	$5.38M	Hold	176,143	–	–	3.6%	9
2015 Q3	$5.88M	Buy	176,143 +12,769	+8%	+$721K	5.1%	7
2015 Q2	$7.58M	Buy	163,374 +32,311	+25%	+$1.21M	5.02%	6
2015 Q1	$4.71M	Buy	131,063 +26,216	+25%	+$1.15M	3.2%	8
2014 Q4	$4.43M	Buy	+104,847	New	+$3.04M	2.16%	9

Other funds holding MRNS

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

TBC

Three Bays Capital Boston, Massachusetts $848M AUM 7.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

New Leaf Venture Partners's MRNS Position: Q2 2018 in Review

New Leaf Venture Partners sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q2 2018, closing a stake of 85,638 shares — an estimated $1.31M sold.

New Leaf Venture Partners first reported a position in MRNS in Q4 2014 and held it in 9 quarters. The position peaked at $7.58M in Q2 2015. 73 funds tracked by Wall St. Rank hold MRNS as of Q2 2018.

New Leaf Venture Partners reported no remaining Marinus Pharmaceuticals, Inc position as of Q2 2018 after selling out during the quarter.
New Leaf Venture Partners sold 85,638 Marinus Pharmaceuticals, Inc shares in Q2 2018, an estimated $1.31M.
New Leaf Venture Partners first reported a position in Marinus Pharmaceuticals, Inc in Q4 2014 and held it in 9 quarters.
New Leaf Venture Partners's Marinus Pharmaceuticals, Inc position peaked at $7.58M in Q2 2015.
73 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q2 2018.

Based on New Leaf Venture Partners's 13F filing for Q2 2018, filed 14 Aug 2018.